Sigachi Industries Ltd Upgraded to Hold by MarketsMOJO on Technical and Valuation Improvements

Quality Assessment: A Mixed Picture Amidst Financial Struggles

Sigachi Industries operates within the Pharmaceuticals & Biotechnology sector, a space known for volatility and regulatory challenges. The company’s recent quarterly financials reveal a significant downturn, with profits after tax (PAT) falling by 25.8% compared to the previous four-quarter average. Operating profit has declined at an annualised rate of -5.82% over the past five years, highlighting persistent headwinds in growth.

Return on Capital Employed (ROCE) remains subdued at 5.7%, with the half-year figure dipping to a low of 6.72%. Return on Equity (ROE) is similarly modest at 6.99%. Despite these figures, the company maintains a conservative capital structure, with an average debt-to-equity ratio of just 0.10 times, indicating low financial leverage and limited risk from debt servicing.

Cash and cash equivalents have also contracted, standing at ₹26.01 crores at half-year, the lowest in recent periods. This liquidity position, combined with underwhelming profitability, has contributed to a cautious quality grade. Domestic mutual funds hold no stake in Sigachi, suggesting limited institutional confidence in the company’s near-term prospects.

Valuation Upgrade: Attractive Metrics Amid Sector Comparisons

The most notable driver behind the rating upgrade is the shift in valuation grade from fair to attractive. Sigachi Industries currently trades at a price of ₹28.78, close to its recent low of ₹16.74 over the past 52 weeks but well below its 52-week high of ₹40.85. Key valuation multiples support this improved assessment:

• Price-to-Earnings (PE) ratio stands at 48.83, which, while elevated, is lower than many peers such as Ind-Swift Labs (53.76) and Shukra Pharma (77.05).
• Enterprise Value to EBITDA ratio is 26.32, again more attractive than several competitors in the sector.
• Enterprise Value to Capital Employed is a modest 1.91, reflecting efficient use of capital relative to enterprise value.
• Dividend yield remains low at 0.35%, consistent with the company’s reinvestment focus.

Compared to its pharmaceutical peers, Sigachi’s valuation metrics suggest it is undervalued relative to sector averages, justifying the upgrade to an attractive valuation grade. This repositioning signals potential upside for investors willing to tolerate the company’s current financial volatility.

Financial Trend: Underperformance and Profitability Concerns

Financially, Sigachi Industries has struggled to keep pace with broader market indices. Over the past year, the stock has declined by 25.17%, significantly underperforming the Sensex’s 9.45% loss and the BSE500’s 2.60% negative return. Year-to-date, the stock is down 7.61%, while the Sensex has fallen 14.61%, indicating some relative resilience in recent months.

Longer-term returns are also disappointing, with a three-year return of -28.07% compared to the Sensex’s 10.55% gain. The company’s operating profit contraction and falling PAT highlight ongoing challenges in generating sustainable earnings growth. These factors weigh on the financial trend grade, which remains cautious despite some stabilisation in recent quarters.

Technicals: Mildly Bullish Signals Prompt Upgrade

The upgrade to Hold is also supported by a shift in technical indicators. The technical trend has moved from bullish to mildly bullish, reflecting a more tempered but positive momentum in the stock price. Key technical signals include:

• MACD on a weekly basis remains bullish, though monthly MACD is bearish, indicating mixed momentum across timeframes.
• Relative Strength Index (RSI) shows no clear signal on weekly or monthly charts, suggesting neutral momentum.
• Bollinger Bands are mildly bullish weekly but bearish monthly, reflecting recent price consolidation.
• Daily moving averages indicate a mildly bullish trend, supporting short-term price stability.
• KST (Know Sure Thing) indicator is bullish weekly but bearish monthly, reinforcing the mixed technical outlook.
• Dow Theory signals are mildly bullish on both weekly and monthly charts, suggesting a cautious positive trend.
• On-Balance Volume (OBV) shows no clear trend weekly but is mildly bullish monthly, indicating some accumulation.

These technical nuances have contributed to the upgrade in the technical grade, signalling that while the stock is not in a strong uptrend, it is showing signs of stabilisation and potential for moderate gains.

Comparative Industry Context and Market Position

Within the Pharmaceuticals & Biotechnology sector, Sigachi Industries is classified as a micro-cap company, which inherently carries higher volatility and risk compared to larger peers. Its valuation metrics, while attractive relative to peers, reflect the market’s cautious stance given the company’s recent financial underperformance.

Peers such as Ind-Swift Labs and Shukra Pharma trade at significantly higher PE and EV/EBITDA multiples, underscoring Sigachi’s relative undervaluation. However, these peers also benefit from stronger financial trends and growth prospects, which Sigachi currently lacks.

The stock’s 52-week trading range between ₹16.74 and ₹40.85 illustrates considerable price volatility. The current price near ₹28.78 suggests a midpoint valuation, supported by mildly bullish technical signals but tempered by weak earnings growth.

Investment Outlook: Hold with Cautious Optimism

The upgrade from Sell to Hold reflects a nuanced view of Sigachi Industries. While the company faces significant financial headwinds, including a 70.7% decline in profits over the past year and negative long-term operating profit growth, its valuation has become more attractive relative to peers. The technical indicators suggest stabilisation, offering a potential base for recovery.

Investors should weigh the company’s low leverage and attractive valuation against its weak profitability and underperformance relative to the broader market. The absence of domestic mutual fund holdings signals limited institutional conviction, which may constrain near-term price appreciation.

Overall, Sigachi Industries represents a cautious hold for investors with a higher risk tolerance, who may benefit from a potential turnaround if financial trends improve and technical momentum strengthens further.

Summary of Rating Change Drivers

• Quality: Financial performance remains weak with declining profits and low returns, but low debt provides some stability.
• Valuation: Upgraded to attractive due to relatively lower PE and EV multiples compared to sector peers.
• Financial Trend: Negative earnings growth and underperformance versus Sensex, though some recent stabilisation noted.
• Technicals: Shift from bullish to mildly bullish trend with mixed signals across MACD, RSI, Bollinger Bands, and moving averages.

These factors collectively prompted the Mojo Grade upgrade from Sell to Hold on 28 Sep 2026, signalling a more balanced risk-reward profile for Sigachi Industries Ltd.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →